Genexis Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.05 M
as on 05-01-2025
- Paid Up Capital ₹ 0.47 M
as on 05-01-2025
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.30 M
as on 05-01-2025
- Revenue 225.39%
(FY 2022)
- Profit 327.97%
(FY 2022)
- Ebitda 149.98%
(FY 2022)
- Net Worth 504.05%
(FY 2022)
- Total Assets 56.88%
(FY 2022)
About Genexis Biotech
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.05 M and a paid-up capital of Rs 0.47 M.
The company currently has active open charges totaling ₹4.30 M.
Jitendra Wagh and Vipul Kumar serve as directors at the Company.
- CIN/LLPIN
U24304GJ2019PTC110276
- Company No.
110276
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Genexis Biotech Private Limited offer?
Genexis Biotech Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Bio Fertilizers, Plastic & Glass Labware, Laboratory Plates, Pharma & Bioanalytical Services, Pharmaceutical Services, Chemical Reagents & Catalysts, Bio Chemicals, Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Genexis Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipul Kumar  | Director | 14-Oct-2019 | Current |
| Jitendra Wagh | Director | 14-Oct-2019 | Current |
Financial Performance of Genexis Biotech.
Genexis Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 225.39% increase. The company also saw a substantial improvement in profitability, with a 327.97% increase in profit. The company's net worth Soared by an impressive increase of 504.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genexis Biotech?
Unlock access to Genexis Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Genexis Peptides Private LimitedActive 2 years 17 daysJitendra Wagh and Vipul Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Nov 2021 | ₹4.30 M | Open |
How Many Employees Work at Genexis Biotech?
Unlock and access historical data on people associated with Genexis Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genexis Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genexis Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
